在韩国人群中探索使用和确定阿波蛋白B测试的参考间隔
Rihwa Choi1,2, Sang Gon Lee1, Eun Hee Lee3
1Department of Laboratory Medicine, Green Cross Laboratories, Yongin 16924, Republic of Korea.
Diagnostics (Basel, Switzerland)
|October 28, 2023
概括
这项研究确定了韩国成年人中Apolipoprotein B (ApoB) 的参考间隔,这对于评估心血管疾病风险至关重要. 这些发现有助于临床医生解释ApoB测试结果,以获得更好的患者护理.
科学领域:
- 临床生物化学 临床生物化学
- 心血管疾病生物标志物 心血管疾病生物标志物
- 人口健康研究 人口健康研究
背景情况:
- 阿波蛋白B (ApoB) 是心血管疾病 (CVD) 风险的一个关键生物标志物.
- 传统的脂质测试可能无法完全捕捉心血管疾病风险,这突出了对ApoB评估的需要.
- 在韩国健康检查中,观察到ApoB测试的不足.
研究的目的:
- 确定韩国成年人正常传统脂质样本的ApoB的参考间隔.
- 将已确定的ApoB间隔与国际临床指南进行比较.
- 提供数据,以便在临床实践中更好地解释ApoB测试结果.
主要方法:
- 分析了264,105个传统的脂质测试套件,识别了464个ApoB测试.
- 在334个样本上使用参数 (平均±2 SD) 和非参数 (95百分位数) 方法确定ApoB参考间隔.
- 通过使用既定和国际截止值,根据性别比较ApoB患病率.
主要成果:
- 男性的参考间隔:46 - 134毫克/分升 (参数),50 - 131毫克/分升 (非参数).
- 女性的参考间隔:49 - 129毫克/分升 (参数),51 - 127毫克/分升 (非参数).
- 在使用性别特异或指南切断时,高ApoB患病率没有显著的基于性别的差异.
结论:
- 该研究为韩国人口提供了重要的ApoB参考间隔.
- 这些间隔将有助于临床医生和实验室准确解释ApoB测试.
- 提高ApoB测试的利用率可以改善韩国的心血管风险评估.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
168
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
168
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
531
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
531


